U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is facing backlash after firing all 17 members of the CDC’s Advisory Committee on Immunization Practices (ACIP) and replacing them with eight new members, several of whom have histories of vaccine skepticism. The move has raised concerns among public health experts and lawmakers, including Senator Bill Cassidy, a Republican and physician from Louisiana who chairs the Senate Health Committee.
Cassidy had previously supported Kennedy's confirmation after receiving assurances that the ACIP structure would remain intact. “If confirmed, he will maintain the CDC’s ACIP without changes,” Cassidy had said during a Senate floor speech. However, Kennedy now says he only promised to let Cassidy choose one candidate for the panel, a pledge he intends to honor.
During a Fox News interview, Kennedy denied violating any agreement. “I told Senator Cassidy I would allow him to put one of his candidates on, which we’re going to do,” he stated. Cassidy’s office later clarified the commitment was about maintaining the ACIP process, not preventing staff changes.
Kennedy defended his decision, citing alleged conflicts of interest among the previous members, though he offered no specific evidence. His reshuffle has drawn sharp criticism from the American Medical Association, which called for an investigation and a reversal of the firings. Critics argue that stacking the panel with vaccine skeptics could undermine public trust in immunization policy.
The ACIP plays a key role in advising the CDC on who should receive vaccines after FDA approval. The controversy has intensified scrutiny of Kennedy’s long-standing views on vaccines, which often contradict mainstream medical consensus. With political and public health stakes high, the debate over ACIP’s direction is far from over.


Venezuela Proposes Amnesty Law and Plans to Transform Helicoide Prison
Christian Menefee Wins Texas Special Election, Narrowing GOP House Majority
U.S. Government Enters Brief Shutdown as Congress Delays Funding Deal
Why Trump’s new pick for Fed chair hit gold and silver markets – for good reasons
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Trump’s Iraq Envoy Mark Savaya Ousted Amid U.S.-Iraq Tensions Over Iran Influence
U.S. Accuses Cuba of Harassing Top Diplomat Amid Rising Tensions
Israel Intensifies Gaza Airstrikes Amid Ceasefire Tensions
South Korea Repatriates 73 Suspected Online Scammers From Cambodia in Major Crackdown
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Trump Proposes Two-Year Shutdown of Kennedy Center Amid Ongoing Turmoil
Trump Appoints Colin McDonald as Assistant Attorney General for National Fraud Enforcement
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 



